Sorrento Therapeutics Inc (SRNE)

[dia76ca]

Which of these 12 could produce income over the next 12 months, let alone at any time now!
1. SEMDEXA
2. RTX
3. COVIMARK
4. VIREX
5. Mpro
6. OQORY(COV-MSC)
7. FUJOVEE (Abivertinib) cancer
8. DAR-T cancer
9. ADNAB cancer
10. PD-L1 in China and US
11. SOFUSA, and the special case,
12. PSS arbitration settlement
Clearly there could be a PSS settlement at any time.
All of the other programs are partnerable at any time.
Semdexa revenue will flow 88% to Sorrento.
COVIMARK approval is overdue but they seem to have aggressive marketing plans.
VIREX could be enormous as its tests roll out.
Mpro fills the need for a better, safer, more effective oral broad spectrum antiviral. And it would be easily partnerable!
And I think Sorrento's new powerful Executive VP will make a difference. Let's go Elizabeth!